-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
CNBX Pharmaceuticals Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2011 to Q4 2023.
- CNBX Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending November 30, 2023 was -$71.8K, a 25.1% increase year-over-year.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$244K, a 117% decline from 2023.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$113K, a 93.3% increase from 2022.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.68M, a 32.6% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)